Effects of serotonin-selective and classical antidepressants on the auditory P300 cognitive potential

Neuropsychobiology

Volumn 40, Issue 4, 1999, Pages 207-213

  Liogier D'Ardhuy, Xavier ^a   Boeijinga, P H ^a   Renault, B ^b   Luthringer, R ^a   Rinaudo, G ^a   Soufflet, L ^a   Toussaint, M ^a   Macher, J P ^a  

^a FORENAP   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Cholinergic; Clomipramine; Event related potential; Fluoxetine; P300; Serotonergic; Tianeptine

Indexed keywords

ANTIDEPRESSANT AGENT; CLOMIPRAMINE; FLUOXETINE; TIANEPTINE;

ADULT; ARTICLE; BRAIN ELECTROPHYSIOLOGY; CHOLINERGIC NERVE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EVENT RELATED POTENTIAL; HUMAN; HUMAN EXPERIMENT; MALE; MONOAMINE NERVE CELL; NEUROCHEMISTRY; NEUROTRANSMISSION; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCALP;

ADULT; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CLOMIPRAMINE; DOUBLE-BLIND METHOD; EVENT-RELATED POTENTIALS, P300; EVOKED POTENTIALS, AUDITORY; FEMALE; FLUOXETINE; HUMANS; MALE; REFERENCE VALUES; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; THIAZEPINES;

EID: 0032720328     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000026621     Document Type: Article

References (25)

1. Hillyard S, Kutas M: Electrophysiology of cognitive processing. Annu Rev Psychol 1983;34: 33-61.
2. Renault B: The visual emitted potentials: Clues for information processing; in Gaillard WK, Ritter W (eds): Tutorials in Event Related Potential Research: Endogenous Components. Amsterdam, North-Holland Publishing Company, 1983, pp 159-175.
3. Callaway E: Human information-processing: Some effects of methylphenidate, age, and scopolamine. Biol Psychiatry 1984;19:649-662.
4. Dierks T, Frölich L, Ihl R, Maurer K: Event related potentials and psychopharmacology, Cholinergic modulation of P300. Pharmacopsychiatry 1994;27:72-74.
5. Hollander E, Davidson M, Mohs RC, Horvath TB, Davis BM, Zemishlany Z, Davis KL: RS 86 in the treatment of Alzheimer's disease: Cognitive and biological effects. Biol Psychiatry 1987;22:1067-1078.
6. Luthringer R, Dago KT, Patat A, Caille P, Curet O, Durieu G, Rinaudo G, Toussaint M, Granier LA, Macher JP: Pharmacoelectroence-phalographic profile of befloxatone, a new reversible MAO-A inhibitor, in healthy subjects. Neuropsychobiology 1996;34:98-105.
7. Nishimura N, Ogura C, Otha I: Effects of the dopamine-related drug bromocriptine on event-related potentials and its relation to the law of initial value. Psychiatry Clin Neurosci 1995;49:79-86.
8. Meador KJ: Cholinergic, serotonergic and GABAergic effects on the ERP. Electroencephalogr Clin Neurophysiol Suppl 1995;44:151-155.
9. Pritchard WS, Raz N, August GJ: No effect of chronic fenfluramine on the P300 component of the event-related potential. Int J Neurosci 1987;35:105-110.
10. Pierson A, Partiot A, Ammar S, Dodin V, Loas G, Jouvent R, Renault B: ERP differences between anxious-impulsive and blunted-affect depressive in-patients; in Ansseau M, von Frenckell R and Franck G (eds): Biological Markers of Depression: State of the Art. Amsterdam, Elsevier, 1991, pp 121-129.
11. Ito J, Yamao S, Fukuda H, Mimori Y, Nakamura S: The P300 event-related potentials in dementia of the Alzheimer type. Correlation between P300 and monoamine metabolites. Electroencephalogr Clin Neurophysiol 1990; 77:174-178.
12. Blier P, de Montigny C: Current advances and trends in the treatment of depression. Trends Pharmacol Sci 1994;15:220-226.
13. Garret C, Debarre F: Classification chimique et relation structure-activité des antidépresseurs; in Editions Médicales Fournier Frères (eds): Séminaire de psychiatrie biologique. Evreux, Hôpital Ste Anne 1984;5:5-52.
14. Jasper HH: The ten twenty electrode system of the International Federation. Electroencephalogr Clin Neurophysiol 1958;10:371-375.
15. Soufflet L, Toussaint M, Luthringer R, Koudou DT, Gresser J, Minor R, Macher JP: A statistical evaluation of the main interpolation methods applied to three dimensional EEG mapping. Electroencephalogr Clin Neurophysiol 1991;79:393-402.
16. Dago KT, Luthringer R, Lengelle R, Rinaudo G, Macher JP: Statistical decision tree: A tool for studying pharmaco-EEG effects of CNS-active drugs. Neuropsychobiology 1994;29:91-96.
17. Barnes JM, Barnes NM, Costall B, Naylor RJ, Tyers MB: 5-HT3 receptors mediate inhibition of acethylcholine release in cortical tissue. Nature 1989;338:762-763.
18. Arato M, Frecska E, Maccrimmon DJ, Guscott R, Saxena B, Tekes K: Serotonergic interhemispheric asymmetry: Neurochemical and pharmaco-EEG evidence. Prog Neuropsychopharmacol Biol Psychiatry 1991;15:759-764.
19. Semlitsch HV, Anderer P, Saletu B, Binder GA, Decker KA: Acute effects of the novel antidepressant venlafaxine on cognitive event-related potentials (P), eye blink rate and mood in young healthy subjects. Int Clin Psychopharmacol 1993;8:155-166.
20. Saletu B, Grunberger J, Anderer P, Linzmayer L, Zyhlarz G: Comparative pharmacodynamic studies with the novel serotonin uptake-enhancing tianeptine and inhibiting fluvoxamine utilizing EEG mapping and psychometry. J Neural Transm 1996;103:191-216.
21. Göthert M, Schlicker E: Relevance of 5-HT autoreceptors for psychotropic drug action. Psychopharmacol Ser 1993;10:38-51.
22. Haddjeri N, Blier P, De Montigny C: Long-term antidepressant treatments result in a tonic activation of forebrain 5-HT1A receptors. J Neurosci 1998;18:10150-10156.
23. Poirier MF, Galinowski A, Amado-Boccara I, Dellaleau B, Gougoulis N, Lôo H: Effects of tianeptine on attention, memory and psychomotor performances using neuropsychological methods in young healthy volunteers. Eur Psychiatry 1993;8:95s-102s.
24. Sutton S, Tueting P, Zubin J, John ER: Information delivery and the sensory evoked potential. Science 1967;155:1437-1439.
25. Knight RT: Contribution of human hippocampal region to novelty detection. Nature 1996; 383:256-259.